indazoles has been researched along with Cancer of Skin in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.13) | 29.6817 |
| 2010's | 23 (71.88) | 24.3611 |
| 2020's | 6 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Balgetir, F; Er, MB; Gonen, M; Yildirim, N | 1 |
| Fujiwara, S; Nakamura, K; Nakano, E; Nishigori, C; Ogura, K; Washio, K | 1 |
| Iwaki, Y; Kamo, R; Nakai, K; Ozawa, T; Tsuruta, D; Watanabe, M | 1 |
| Maeda, T; Nakano, E; Namikawa, K; Oashi, K; Shibata, T; Takahashi, A; Teramoto, Y; Tsutsumida, A; Yamazaki, N; Yokota, K | 1 |
| Distel, LV; Fietkau, R; Hecht, M; Heinzerling, L; Jost, T; Knippertz, I; Weigert, V | 1 |
| Adamski, H; Battistella, M; Bertucci, F; Da Meda, L; Dalac, S; Delyon, J; Ghrieb, Z; Guillot, B; Jouary, T; Lebbe, C; Leccia, MT; Meyer, N; Mortier, L; Mourah, S; Pedeutour, F; Porcher, R; Vicaut, E | 1 |
| Keam, B; Kim, DW; Kim, M; Kim, SH; Kim, TM; Kim, YJ; Kwak, Y; Moon, KC; Park, C | 1 |
| Freeman, ML; Gibney, GT; Knepper, TC; McLeod, HL; Russell, JS | 1 |
| Chandramohan, J; George, AA; Georgy, JT; Mathuram, AJ | 1 |
| Bhatia, S; Blom, A; Nghiem, P; Olencki, T; Parvathaneni, U; Tarabadkar, ES; Thomas, H | 1 |
| Adachi, A; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M | 1 |
| Hasunuma, N; Manabe, M; Osada, SI; Toyoshima, A; Yamada, K; Yamada, M | 1 |
| Hata, H; Imafuku, K; Kitamura, S; Maeda, T; Masuzawa, M; Shimizu, H; Yanagi, T | 1 |
| Näär, AM; Wu, S | 1 |
| Creixell, P; Jeschke, GR; Kim, J; Linding, R; Longden, J; Poulikakos, PI; Rosen, N; Santini, CC; Schoof, EM; Simpson, CD; Turk, BE; Wu, X | 1 |
| Arepalli, SK; Jung, JK; Kim, Y; Lee, C; Lee, H; Lee, K | 1 |
| Bosenberg, M; De, SK; Feng, Y; Kluger, H; Lazova, R; Li, JL; Pellecchia, M; Rickert, R; Ronai, ZA; Ruller, C; Scortegagna, M | 1 |
| Abe, K; Asai, M; Koike, Y; Ogawa, F; Tanioka, M; Tomita, H; Utani, A | 1 |
| Chen, S; Cohen-Sola, KA; Goydos, JS; Jeong, BS; Koo, J; Li, J; Lin, Y; Mehnert, JM; Shin, SS; Wen, Y | 1 |
| Aldabagh, B; Joo, J; Yu, SS | 1 |
| Bosenberg, M; Brown, K; Davies, MA; De, SK; Feng, Y; Halaban, R; Langdon, CG; Lau, E; Meeth, K; Pellecchia, M; Platt, JT; Ronai, ZA; Scortegagna, M; Sereduk, C; Stern, DF; Yin, H; Zhang, T | 1 |
| Miura, H; Shirai, H | 1 |
| Haga, N; Hata, H; Homma, E; Imafuku, K; Kitamura, S; Shimizu, H | 1 |
| Abarzúa, Á; Giesen, L; González, S; Molgó, M | 1 |
| Cheng, PF; Dummer, R; Goldinger, SM; Guenova, E; Jaberg-Bentele, N; Kunz, M; Levesque, MP; Mangana, J; Nagel, HW; Nägeli, M; Thurneysen, S; Ziegler, M | 1 |
| Oashi, K; Ogata, D; Suzuki, K; Tsuchida, T; Yamazaki, N; Yanagisawa, H | 1 |
| Hirabayashi, M; Hoashi, T; Nakajima, R; Saeki, H; Takahashi, N | 1 |
| Fujita, H; Kadono, T; Kimura, T; Masui, Y; Miyagaki, T; Miyagawa, T; Saigusa, R; Sato, S; Yamada, D; Yoshizaki, A | 1 |
| Charlton, A; Chong, ML; Dar, M; Davids, M; Davids, MS; Goh, BC; Hodge, J; Laubscher, K; Ng, SS; Soong, R | 1 |
| Bose, A; Lowe, DB; Rao, A; Storkus, WJ | 1 |
| Battelli, T; Bellocci, M; Cavaliere, R; De Martino, C; Di Filippo, F; Gallo Curcio, C; Giustini, L; Manocchi, D; Mattioli, R; Rinaldi, M | 1 |
| Ormea, F | 1 |
2 review(s) available for indazoles and Cancer of Skin
| Article | Year |
|---|---|
Fatal Acute Motor Axonal Neuropathy Induced by Nivolumab: A Case Report and Literature Review.
Topics: Aged; Antineoplastic Agents, Immunological; Axons; Carcinoma, Renal Cell; Drug Substitution; Fatal Outcome; Humans; Indazoles; Kidney Neoplasms; Lymphatic Metastasis; Male; Motor Neurons; Nivolumab; Paraparesis; Polyneuropathies; Pyrimidines; Skin Neoplasms; Sulfonamides | 2019 |
Merkel cell carcinoma: current status of targeted and future potential for immunotherapies.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Benzamides; Biomarkers; Carcinoma, Merkel Cell; CD56 Antigen; Electrochemotherapy; Hepatitis A Virus Cellular Receptor 2; Humans; Imatinib Mesylate; Immunotherapy; Immunotherapy, Adoptive; Indazoles; Inhibitor of Apoptosis Proteins; Interferons; Interleukin-12; Interleukin-2; Ipilimumab; Lymphatic Metastasis; Membrane Proteins; Merkel cell polyomavirus; Oligonucleotides, Antisense; Piperazines; Polyomavirus Infections; Prognosis; Programmed Cell Death 1 Receptor; Pyrimidines; Receptors, Somatomedin; Skin Neoplasms; Somatostatin; Sulfonamides; Survivin; Thionucleotides; TOR Serine-Threonine Kinases | 2014 |
2 trial(s) available for indazoles and Cancer of Skin
| Article | Year |
|---|---|
A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans.
Topics: Adult; Aged; Biomarkers, Tumor; Dermatofibrosarcoma; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Response Evaluation Criteria in Solid Tumors; Skin; Skin Neoplasms; Sulfonamides; Tumor Burden | 2021 |
An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Drug Administration Schedule; Female; Humans; Indazoles; Infusions, Intravenous; Male; Melanoma; Paclitaxel; Pyrimidines; Skin Neoplasms; Sulfonamides; Treatment Outcome; Up-Regulation | 2016 |
28 other study(ies) available for indazoles and Cancer of Skin
| Article | Year |
|---|---|
Pazopanib as a potential chemotherapy for cutaneous angiosarcoma: A case series of 10 patients from a single institution.
Topics: Hemangiosarcoma; Humans; Indazoles; Pyrimidines; Skin Neoplasms; Sulfonamides | 2020 |
Successful long-term treatment with pazopanib after prior interleukin-2 therapy in patients with metastatic cutaneous angiosarcoma of the scalp.
Topics: Hemangiosarcoma; Humans; Indazoles; Interleukin-2; Pyrimidines; Scalp; Skin Neoplasms; Sulfonamides | 2020 |
A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Indazoles; Male; Middle Aged; Paclitaxel; Prognosis; Pyrimidines; Research Design; Salvage Therapy; Skin Neoplasms; Sulfonamides; Young Adult | 2020 |
PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts.
Topics: Apoptosis; Cell Survival; Chemoradiotherapy; Drug Interactions; Fibroblasts; G2 Phase Cell Cycle Checkpoints; Homologous Recombination; Humans; Indazoles; Melanoma; Phthalazines; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Primary Cell Culture; Skin; Skin Neoplasms; Tumor Cells, Cultured | 2020 |
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Indazoles; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Pyrimidines; Retrospective Studies; Skin Neoplasms; Sulfonamides; Survival Rate | 2021 |
Clinical Response to Pazopanib in a Patient With KDR-Mutated Metastatic Basal Cell Carcinoma.
Topics: Carcinoma, Basal Cell; DNA Mutational Analysis; DNA, Neoplasm; Humans; Indazoles; Male; Middle Aged; Mutation; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Skin Neoplasms; Sulfonamides; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Renal cell carcinoma presenting as a cutaneous horn and nodules on the gingiva and scalp.
Topics: Acute Kidney Injury; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Diagnosis, Differential; Fatal Outcome; Gingiva; Humans; Indazoles; Kidney Neoplasms; Male; Middle Aged; Pyrimidines; Scalp; Skin Neoplasms; Sulfonamides | 2017 |
Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients.
Topics: Aged; Angiogenesis Inhibitors; Anilides; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Humans; Indazoles; Male; Middle Aged; Neoplasm Metastasis; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Skin Neoplasms; Sulfonamides | 2018 |
Long-term survival of a patient with neurofibromatosis type 1 diagnosed with multiple malignant peripheral nerve sheath tumors.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Humans; Indazoles; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Second Primary; Nerve Sheath Neoplasms; Neurofibromatosis 1; Pyrimidines; Radiotherapy, Adjuvant; Skin; Skin Neoplasms; Sulfonamides; Time Factors; Treatment Outcome | 2019 |
Prevention of tumor progression in Stewart-Treves syndrome with a low dose of pazopanib.
Topics: Aged; Amputation Stumps; Amputation, Surgical; Biopsy; Chemoradiotherapy; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemangiosarcoma; Humans; Indazoles; Leg; Lymphangiosarcoma; Neoplasm Recurrence, Local; Progression-Free Survival; Protein Kinase Inhibitors; Pyrimidines; Skin; Skin Neoplasms; Sulfonamides | 2019 |
Evaluation of pazopanib cytotoxicity to normal vascular endothelial cells in vitro: A comment on Goto et al.
Topics: Angiogenesis Inhibitors; Apoptosis; Cell Line, Tumor; Cell Survival; Dermis; Endothelium, Vascular; Fibroblasts; Hemangiosarcoma; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Pyrimidines; Skin Neoplasms; Sulfonamides; Toxicity Tests | 2019 |
SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait.
Topics: Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Fatty Acids; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Kaplan-Meier Estimate; Melanoma; Neoplasm Proteins; Neoplasms; Piperazines; Prognosis; Proto-Oncogene Proteins B-raf; RNA Interference; RNA Polymerase II; RNA, Small Interfering; Skin Neoplasms; Sterol Regulatory Element Binding Protein 1; Transcription, Genetic; Vemurafenib | 2019 |
Global view of the RAF-MEK-ERK module and its immediate downstream effectors.
Topics: Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; Indazoles; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinase Kinases; Oximes; Phosphorylation; Piperazines; Proteome; Proteomics; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Skin Neoplasms | 2019 |
Synthesis of N-arylindazole-3-carboxamide and N-benzoylindazole derivatives and their evaluation against α-MSH-stimulated melanogenesis.
Topics: alpha-MSH; Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Indazoles; Melanoma, Experimental; Mice; Molecular Structure; Skin Neoplasms; Structure-Activity Relationship | 2019 |
Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Knockout Techniques; Humans; Indazoles; Lung Neoplasms; Lymphatic Metastasis; Melanoma, Experimental; Mice; Mice, Knockout; Mutation, Missense; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Pyrimidines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Skin Neoplasms; Tissue Array Analysis | 2014 |
Angiosarcoma of the scalp successfully treated with pazopanib.
Topics: Angiogenesis Inhibitors; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Scalp; Skin Neoplasms; Sulfonamides | 2014 |
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Heterocyclic Compounds, 3-Ring; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Inhibitor of Apoptosis Proteins; Interleukin-8; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Metabotropic Glutamate; Riluzole; Signal Transduction; Sirolimus; Skin Neoplasms; Survivin; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.
Topics: Animals; Benzoates; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Immediate-Early Proteins; Indazoles; Lymphatic Metastasis; Melanoma; Mice, Knockout; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Skin; Skin Neoplasms | 2015 |
Low-dose administration of oral pazopanib for the treatment of recurrent angiosarcoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Female; Hemangiosarcoma; Humans; Indazoles; Male; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Pyrimidines; Skin Neoplasms; Sulfonamides; Treatment Outcome | 2015 |
Pazopanib can preserve cosmetic quality of life even in end-stage angiosarcoma.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Indazoles; Protein Kinase Inhibitors; Pyrimidines; Quality of Life; Scalp; Skin Neoplasms; Sulfonamides | 2015 |
Nasal tumoral lesion: challenge. Cutaneous metastasis of renal cell carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Biomarkers, Tumor; Biopsy; Carcinoma, Renal Cell; Fatal Outcome; Humans; Immunohistochemistry; Indazoles; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Pyrimidines; Skin Neoplasms; Sulfonamides; Time Factors; Treatment Outcome | 2015 |
Pazopanib treatment slows progression and stabilizes disease in patients with taxane-resistant cutaneous angiosarcoma.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bridged-Ring Compounds; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Hemangiosarcoma; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Retrospective Studies; Skin Neoplasms; Sulfonamides; Taxoids | 2016 |
Paradoxical antitumor effects of pazopanib in a cutaneous angiosarcoma patient.
Topics: Aged; Angiogenesis Inhibitors; Disease Progression; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Indazoles; Male; Pyrimidines; Skin Neoplasms; Sulfonamides | 2017 |
Pazopanib induced a partial response in a patient with metastatic fibrosarcomatous dermatofibrosarcoma protuberans without genetic translocations resistant to mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy and gemcitabine-docetaxel chemothera
Topics: Abdomen; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Dermatofibrosarcoma; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Gemcitabine; Humans; Ifosfamide; Indazoles; Male; Mesna; Middle Aged; Pyrimidines; Skin Neoplasms; Sulfonamides | 2017 |
Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma.
Topics: Aged; Base Sequence; Biomarkers; Carcinoma, Merkel Cell; DNA Mutational Analysis; Fatal Outcome; Female; Humans; Indazoles; Keratins; Mutation; Neoplasm Metastasis; Phosphopyruvate Hydratase; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Scalp; Skin Neoplasms; Sulfonamides | 2009 |
Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cancer Vaccines; Cell Line, Tumor; Combined Modality Therapy; Dendritic Cells; Endothelial Cells; Female; Imidazoles; Indazoles; Interleukin-12; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Melanoma; Mice; Mice, Inbred C57BL; Ovalbumin; Peptide Fragments; Protein Kinase Inhibitors; Skin Neoplasms; T-Lymphocytes; Time Factors; Tumor Burden; Tumor Microenvironment | 2012 |
Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Humans; Hyperthermia, Induced; Indazoles; Melanoma; Mice; Neoplasms; Pyrazoles; Skin Neoplasms | 1984 |
[The external treatment of dermatoses (author's transl)].
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Dermatologic Agents; Drug Interactions; Glucocorticoids; Humans; Indazoles; Ointments; Pharmaceutical Vehicles; Precancerous Conditions; Psoriasis; Skin; Skin Absorption; Skin Diseases; Skin Neoplasms | 1974 |